Background Available data show that COVID-19 vaccines may be less effective in
immunocompromised populations, who are at increased risk of severe COVID-19 …

The COVID-19 pandemic has profound adverse effects on the population on dialysis.
Patients requiring dialysis are at an increased risk of SARS-CoV-2 infection and mortality …

Rationale & Objective During the coronavirus disease 2019 (COVID-19) pandemic, patients
receiving maintenance dialysis are a highly vulnerable population due to their comorbidities …

Over the course of the COVID-19 pandemic, numerous studies have aimed to address the
challenges faced by patients with kidney disease and their caregivers. These studies …

Results After the first vaccine dose, four of 22 (18%) patients on dialysis compared with 43 of
46 (93%) healthy controls developed positive anti-S1 IgG, with a median anti-S1 IgG index …

Abstract Background Coronavirus disease 2019 (COVID-19) has exposed haemodialysis
(HD) patients and kidney transplant (KT) recipients to an unprecedented life-threatening …

Background Patients receiving maintenance dialysis represent a high-risk, immune-
compromised population with 15%–25% COVID-19 mortality rate who were unrepresented …

Importance There is a need for studies to evaluate the risk factors for COVID-19 and
mortality among the entire Medicare long-term dialysis population using Medicare claims …

Up to 87% of patients hospitalized with coronavirus disease 2019 (COVID-19) experience
chronic sequelae following infection. The long-term impact of COVID-19 infection on kidney …

Kidney impairment in hospitalized patients with SARS-CoV-2 infection is associated with
increased in-hospital mortality and worse clinical evolution, raising concerns towards …